Drugs / Z-208
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00731445 | Jul 2008 → Jan 2012 | hepatocellular carcinoma | Zeria Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Z-208 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731445 ↗ |
| Route | Oral | “Oral pills taken daily; 8mg, 12mg, 16mg, 4mg” NCT00731445 ↗ |